Publication:
Hematic antegrade repriming: a reproducible method to decrease the cardiopulmonary bypass Insult

Simple item page
dc.contributor.authorBlanco Morillo, Juan
dc.contributor.authorArribas Leal, José María
dc.contributor.authorFarina, Piero
dc.contributor.authorFernández González, Angel Luis
dc.contributor.authorSornichero Caballero, Ángel
dc.contributor.authorRamírez Romero, Pablo
dc.contributor.authorChen, Tyler N.
dc.contributor.authorSalmerón Martínez, Diego
dc.contributor.authorCánovas López, Sergio
dc.contributor.departmentCirugía, Pediatría y Obstetricia y Ginecología
dc.date.accessioned2024-07-18T11:02:51Z
dc.date.available2024-07-18T11:02:51Z
dc.date.issued2021-03-15
dc.descriptionThis document is the Published version of a Published Work that appeared in final form in Journal of Extracorporeal Technology. To access the final edited and published work see https://doi.org/10.1051/ject/202153075
dc.description.abstractThe current practice of cardiopulmonary bypass (CPB) requires a preoperative priming of the circuit that is frequently performed with crystalloid solutions. Crystalloid priming avoids massive embolism but is unable to eliminate all microbubbles contained in the circuit. In addition, it causes a sudden hemodilution which is correlated with transfusion requirements and an increased risk of cognitive impairment. Several repriming techniques using autologous blood, collectively termed retrograde autologous priming (RAP), have been demonstrated to reduce the hemodilutional impact of CPB. However, the current heterogeneity in the practice of RAP limits its evidence and benefits. Here, we describe hematic antegrade repriming as an easy and reliable method that could be applied with any circuit in the market to decrease transfusion requirements, emboli, and inflammatory responses, reducing costs and the impact of CPB on postoperative recovery.es
dc.formatapplication/pdfes
dc.format.extent5es
dc.identifier.citationJ Extra Corpor Technol. 2021 53:75–9
dc.identifier.doihttps://doi.org/10.1051/ject/202153075
dc.identifier.issnPrint: 0022-1058
dc.identifier.issnElectronic: 2969-8960
dc.identifier.urihttp://hdl.handle.net/10201/143202
dc.languageenges
dc.publisherEDPSciences
dc.relationSin financiación externa a la Universidades
dc.relation.publisherversionhttps://ject.edpsciences.org/articles/ject/abs/2021/01/ject-53-75/ject-53-75.html
dc.rights.accessRightsinfo:eu-repo/semantics/restrictedAccess
dc.subjectCardiopulmonary bypasses
dc.subjectHematic priminges
dc.subjectHemodilutiones
dc.subjectMicroembolies
dc.subjectMiECCes
dc.titleHematic antegrade repriming: a reproducible method to decrease the cardiopulmonary bypass Insultes
dc.typeinfo:eu-repo/semantics/articlees
dspace.entity.typePublicationes
Files
Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
ject-53-75.pdf
Size:
453.26 KB
Format:
Adobe Portable Document Format
Description:
Download
License bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
license.txt
Size:
2.26 KB
Format:
Item-specific license agreed upon to submission
Description:
Download
Collections
Artículos